Skip to main content
Clinical Trials/CTRI/2025/01/079681
CTRI/2025/01/079681Not yet recruitingPhase 2

A CLINICAL STUDY TO EVALUATE THE ANALGESIC EFFICACY OF SHOOLPRASHAMANAM MAHAKASHAYAM GHAN VATI ALONG WITH DASHMOOLA KWATH IN PAIN [SHOOL] MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

Pt khushilal sharma Government Autonomous colllege and institue bhopal mp1 site in 1 country40 target enrollmentStarted: February 15, 2025Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
It is expected that at the end of the study, we would be able to demonstrate and explain the efficacy of Shoolprashamanam mahakashayam ghan vati along with Dashmoola kwath in the pain management of Amavat (RA).

Study Overview

Brief Summary

It is expected that at the end of the study we would be able to demonstrate and explain the efficacy of shoolprashamanam mahakashayam ghan vati along with Dashmoola kwath in the management of Amavata( rheumatois arthritis)

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
26.00 Year(s) to 55.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patient fulfilling the American college of Rheumatology revised criteria of RA.
  • Sign and symptoms of Amavata which are mention in our classics.
  • Patients willing and able to participate in the study and give written consent form.

Exclusion Criteria

  • patients below 26 year and above 55 years Patients who develop secondary complications of R.A. e.g. Pleuro-pericardial disease, severely damaged joint with bed ridden patients and severe joint and crippling deformity .
  • Patient having any other serious illness e.g. Hepatic/renal failure, severe GERD.
  • Patients with diagnosed other arthritis like Gouty arthritis, tuberculosis or psoriatic arthritis etc.
  • Immunocompromised patient, cancer, AIDS, heart disease, polycystic kidney disease.
  • Pt. who are not willing to give consent.

Outcomes

Primary Outcomes

It is expected that at the end of the study, we would be able to demonstrate and explain the efficacy of Shoolprashamanam mahakashayam ghan vati along with Dashmoola kwath in the pain management of Amavat (RA).

Time Frame: 12 months

Secondary Outcomes

  • It is expected that at the end of the study, we would be able to manage pain intensity of Aamvata with Shoolprashmanam Mahakashyam ghan vati along with Dashmool kwath

Investigators

Sponsor
Pt khushilal sharma Government Autonomous colllege and institue bhopal mp
Sponsor Class
Government funding agency
Responsible Party
Principal Investigator
Principal Investigator

Dr urvashi chandrol

pt khushilal sharma gov Ayurvedic college bhopal mp

Study Sites (1)

Loading locations...

Similar Trials